ARMISTICE CAPITAL, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2020$1,156,000
-93.9%
428,000
-92.4%
0.04%
-96.6%
Q3 2019$18,812,000
-4.7%
5,624,000
-6.3%
1.25%
+0.2%
Q2 2019$19,740,000
-36.7%
6,000,000
-41.7%
1.24%
-27.1%
Q1 2019$31,209,000
+11.4%
10,300,0000.0%1.71%
-19.5%
Q4 2018$28,016,000
-8.6%
10,300,000
+12.9%
2.12%
+15.4%
Q3 2018$30,643,000
-1.4%
9,120,000
-24.3%
1.84%
-9.4%
Q2 2018$31,089,000
+12.5%
12,050,000
-4.1%
2.03%
-3.9%
Q1 2018$27,632,000
+82.7%
12,560,000
+65.3%
2.11%
+40.1%
Q4 2017$15,124,000
+11.1%
7,600,000
+81.0%
1.51%
-5.9%
Q3 2017$13,608,000
-25.9%
4,200,000
-26.3%
1.60%
-31.5%
Q2 2017$18,354,000
-25.7%
5,700,000
-34.5%
2.34%
-54.2%
Q1 2017$24,708,000
-3.6%
8,700,000
-20.9%
5.10%
-15.9%
Q4 2016$25,630,000
+24.0%
11,000,000
-10.6%
6.06%
-8.6%
Q3 2016$20,664,000
+27.5%
12,300,000
-20.3%
6.63%
+7.5%
Q2 2016$16,202,000
+20.9%
15,430,000
+0.2%
6.17%
+17.2%
Q1 2016$13,405,000
-16.3%
15,405,703
+16.4%
5.26%
-7.9%
Q4 2015$16,020,000
+13.5%
13,240,000
+59.5%
5.72%
+18.6%
Q3 2015$14,110,000
+6.0%
8,300,000
+29.7%
4.82%
+0.8%
Q2 2015$13,312,000
+29.3%
6,400,000
+68.4%
4.78%
+4.8%
Q1 2015$10,298,000
+54.1%
3,800,000
+46.2%
4.56%
+42.1%
Q4 2014$6,682,0002,600,0003.21%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders